Efficacy and safety of intracoronary versus intravenous tirofiban in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A meta-analysis of randomized controlled trials

Efficacy and safety of intracoronary versus intravenous tirofiban in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A meta-analysis of randomized controlled trials

Background: Effective antiplatelet therapy is critical for patients with ST-segment elevation myocardial infarction (STEMI) and receiving primary percutaneous coronary interventions (PPCI). Intracoronary (IC) and intravenous (IV) administration of tirofiban are commonly used during the procedure of...

Full description

Bibliographic Details
Main Authors:	Rui Tian, Rugang Liu, Jiajun Zhang, Yong Li, Shujian Wei, Feng Xu, Xiaoxing Li, Chuanbao Li
Format:	Article
Language:	English
Published:	Elsevier 2023-05-01
Series:	Heliyon
Subjects:	ST-elevation myocardial infarction Percutaneous coronary intervention Tirofiban Meta-analysis Randomized controlled trial
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844023030499

Similar Items

Efficacy and safety of abciximab versus tirofiban in addition to ticagrelor in STEMI patients undergoing primary percutaneous intervention
by: Pablo Revilla-Martí, et al.
Published: (2022-02-01)

Efficacy and safety of quadruple therapy including tirofiban in the treatment of Chinese NSTE-ACS patients failing to receive timely percutaneous coronary intervention
by: Li L, et al.
Published: (2017-11-01)

A Simple Clinical Pre-procedure Risk Model for Predicting Thrombocytopenia Associated With Periprocedural Use of Tirofiban in Patients Undergoing Percutaneous Coronary Intervention
by: Yi-Hu Yi, et al.
Published: (2018-12-01)

Analysis of the Best Timing for Applying Tirofiban in PCI Operation for the Patients with ST Segment Elevation Myocardial Infarction
by: Lei Zhang, et al.
Published: (2015-01-01)

High bolus tirofiban vs abciximab in acute STEMI patients undergoing primary PCI - The tamip study
by: Mohammed A Balghith
Published: (2012-01-01)

EFFICACY OF INTRAVENOUS TIROFIBAN THERAPY IN LACUNAR STROKE PATIENTS
by: Ahmet Yabalak, et al.
Published: (2023-06-01)

Severe thrombocytopenia induced by tirofiban after percutaneous coronary intervention: a case report
by: Ze-Mu Wang, et al.
Published: (2023-10-01)

Effects of Intracoronary Pro-urokinase or Tirofiban on Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: A Multi-Center, Placebo-Controlled, Single-Blind, Randomized Clinical Trial
by: Dong Huang, et al.
Published: (2021-08-01)

Association of thrombocytopenia and infection in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention
by: Litao Wang, et al.
Published: (2021-08-01)

Electrocardiogram predictors of multivessel disease in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention
by: Ajay Kumar Sharma, et al.
Published: (2021-01-01)

Cardioprotective Effects of Intracoronary Morphine in ST‐Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: A Prospective, Randomized Trial
by: Hye Bin Gwag, et al.
Published: (2017-04-01)

Prospective pilot study of tirofiban in progressive stroke after intravenous thrombolysis
by: Yan Zhang, et al.
Published: (2022-10-01)

Percutaneous coronary intervention in the elderly with ST-segment elevation myocardial infarction
by: Gao L, et al.
Published: (2014-07-01)

Adjunct Intraarterial or Intravenous Tirofiban Versus No Tirofiban After Successful Recanalization of Basilar Artery Occlusion Stroke: The BASILAR Registry
by: Huagang Li, et al.
Published: (2024-03-01)

Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention
by: Yan Li, et al.
Published: (2020-01-01)

Hemorragia alveolar asociada con tirofiban
by: Alexander Aguilar Arias, et al.
Published: (2023-03-01)

Treatment of intravenous thrombolysis with half-dose recombinant human prourokinase reduces the rate of tirofiban use during early routine catheterization period
by: Chao Jiang, et al.
Published: (2022-07-01)

No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction
by: Sanjiv Gupta, et al.
Published: (2016-07-01)

New in recommendations on primary percutaneous coronary intervention for myocardial infarction with ST segment elevation
by: M.Т. Vatutin, et al.
Published: (2016-09-01)

Smoker's Paradox in Patients With ST‐Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
by: Tanush Gupta, et al.
Published: (2016-04-01)

SAFETY OF TIROFIBAN FOR PATIENTS WITH ACUTE ISCHEMIC STROKE IN ROUTINE CLINICAL PRACTICE
by: Yan-Jun Zhang, et al.
Published: (2014-04-01)

Case report: reuse of tirofiban leads to very severe thrombocytopenia
by: Yuqing Li, et al.
Published: (2023-05-01)

High-dose bolus tirofiban versus low-dose bolus in patients with acute coronary syndrome undergoing percutaneous coronary intervention
by: Taner Ulus, et al.
Published: (2017-03-01)

Tirofiban induced diffuse alveolar hemorrhage
by: Deepak Kadeli, et al.
Published: (2018-05-01)

Prognostic Value of Metabolic Syndrome in Patients With Non-ST Elevated Myocardial Infarction Undergoing Percutaneous Coronary Intervention
by: Li-Hong Zhao, et al.
Published: (2022-06-01)

Comparison of the effect of ticagrelor combined with tirofiban versus clopidogrel combined with tirofiban on inflammation response and prognosis of patients with unstable angina pectoris in long term follow‐up
by: Li Deng, et al.
Published: (2021-11-01)

Association between clinical parameters and ST-segment resolution after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction
by: Ramūnas Unikas, et al.
Published: (2016-01-01)

Incidence, Predictors and Outcomes of Contrast Induced Nephropathy in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
by: Mohamed Khalfallah, et al.
Published: (2021-08-01)

Association of admission testosterone level with ST-segment resolution in male patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
by: Ahmad Separham, et al.
Published: (2017-07-01)

Mechanical Solitaire Thrombectomy with Low-Dose Booster Tirofiban Injection
by: Duck-Ho Goh, et al.
Published: (2016-09-01)

The impact of intraarterial, intravenous, and combined tirofiban on endovascular treatment for acute intracranial atherosclerotic occlusion
by: Zhiping Bu, et al.
Published: (2024-02-01)

Population Density Analysis of Percutaneous Coronary Intervention for ST‐Segment–Elevation Myocardial Infarction in Japan
by: Kyohei Yamaji, et al.
Published: (2020-08-01)

Safety and efficacy of low-dose and long-course tirofiban in large hemispheric infarction
by: Yinqin Hu, et al.
Published: (2022-09-01)

Impact of upstream high bolus dose tirofiban on left ventricular systolic function in patients with acute anterior myocardial infarction treated by primary coronary intervention
by: Haitham Galal, et al.
Published: (2014-09-01)

Impact of Stress Hyperglycemia on No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
by: Mohamed Khalfallah, et al.
Published: (2022-03-01)

The efficacy and safety of continuous intravenous tirofiban for acute ischemic stroke patients treated by endovascular therapy: a meta-analysis
by: Mengmeng Wang, et al.
Published: (2024-04-01)

Predictive role of fragmented QRS in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
by: Sunil Bobate, et al.
Published: (2023-06-01)

Baseline hemoglobin and creatinine clearance as independent risk factors for 30-day event rate in patients of acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
by: Richa Agrawal, et al.
Published: (2018-01-01)

Low-dose intravenous tirofiban infusion after endovascular recanalization for non-acute middle cerebral artery occlusion
by: Zhang Xi, et al.
Published: (2022-12-01)

Feasibility of primary percutaneous coronary intervention via the distal radial approach in patients with ST-elevation myocardial infarction
by: Yongcheol Kim, et al.
Published: (2021-03-01)